Innova Captab Limited (INNOVACAP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Innova Captab Limited (INNOVACAP) has a cash flow conversion efficiency ratio of 0.079x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs306.43 Million ≈ $3.31 Million USD) by net assets (Rs3.89 Billion ≈ $42.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Innova Captab Limited - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Innova Captab Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Innova Captab Limited for a breakdown of total debt and financial obligations.
Innova Captab Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Innova Captab Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thonburi Healthcare Grp Pcl
BK:THG
|
0.024x |
|
LAY-OUT Planning Consultants Co. Ltd.
SHE:300989
|
N/A |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
|
0.010x |
|
Jiangsu Lidao New Material Co Ltd Class A
SHG:603937
|
0.018x |
|
UPC Technology Corp
TW:1313
|
-0.018x |
|
Rieter Holding AG
SW:RIEN
|
-0.130x |
|
Eastnine AB (publ)
ST:EAST
|
0.012x |
|
Shanxi Yongdong Chemistry Industry Co Ltd
SHE:002753
|
0.000x |
Annual Cash Flow Conversion Efficiency for Innova Captab Limited (2018–2025)
The table below shows the annual cash flow conversion efficiency of Innova Captab Limited from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Innova Captab Limited worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs9.59 Billion ≈ $103.76 Million |
Rs638.44 Million ≈ $6.90 Million |
0.067x | -62.22% |
| 2024-03-31 | Rs8.31 Billion ≈ $89.86 Million |
Rs1.46 Billion ≈ $15.83 Million |
0.176x | -14.57% |
| 2023-03-31 | Rs3.26 Billion ≈ $35.21 Million |
Rs671.24 Million ≈ $7.26 Million |
0.206x | -26.98% |
| 2022-03-31 | Rs2.09 Billion ≈ $22.56 Million |
Rs588.98 Million ≈ $6.37 Million |
0.282x | +7.15% |
| 2021-03-31 | Rs1.45 Billion ≈ $15.66 Million |
Rs381.60 Million ≈ $4.13 Million |
0.263x | +224.86% |
| 2020-03-31 | Rs3.80 Billion ≈ $41.06 Million |
Rs307.97 Million ≈ $3.33 Million |
0.081x | -86.89% |
| 2019-03-31 | Rs305.11 Million ≈ $3.30 Million |
Rs188.72 Million ≈ $2.04 Million |
0.619x | +138.16% |
| 2018-03-31 | Rs626.18 Million ≈ $6.77 Million |
Rs162.62 Million ≈ $1.76 Million |
0.260x | -- |
About Innova Captab Limited
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhib… Read more